Envoy Medical (COCH) Change in Accured Expenses (2021 - 2026)
Envoy Medical (COCH) reported Change in Accured Expenses of $664000.0 for Q1 2026, up 233.67% on a YoY basis from $199000.0 in Q1 2025, and up 161.25% sequentially from -$1.1 million in Q4 2025.
Envoy Medical (COCH) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Envoy Medical (COCH) has 6 years of Change in Accured Expenses data on file, last reported at $664000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 233.67% year-over-year to $664000.0; the trailing twelve-month figure through Mar 2026 stood at -$403000.0 (down 127.85% YoY), and the FY2025 full-year result was -$868000.0, down 197.42% from the prior year.
- Change in Accured Expenses rose to $664000.0 in Q1 2026, from -$1.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.3 million in Q3 2024 to a low of -$1.1 million in Q4 2025.
- A 5-year average of $42705.9 and a median of $113000.0 in 2025 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses soared 4538.28% in 2022 and plunged 432.49% in 2023, its largest moves.
- Tracing COCH's Change in Accured Expenses over 5 years: stood at $237000.0 in 2022, then sank by 432.49% to -$788000.0 in 2023, then surged by 217.64% to $927000.0 in 2024, then plunged by 216.94% to -$1.1 million in 2025, then surged by 161.25% to $664000.0 in 2026.
- Business Quant data shows COCH's Change in Accured Expenses at $664000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$96000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | 664,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 664,000.00 |
| Mar 31, 2026 | 664,000.00 |
| Dec 31, 2025 | -1.08 Mn |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -96,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Dec 31, 2024 | 927,000.00 |
| Dec 31, 2024 | 927,000.00 |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | -982,000.00 |
| Jun 30, 2024 | -982,000.00 |
| Mar 31, 2024 | -357,000.00 |
| Mar 31, 2024 | -357,000.00 |
| Dec 31, 2023 | -788,000.00 |
| Dec 31, 2023 | -788,000.00 |